Product Introduction:
Varitide Injection contains Teriparatide, a recombinant form of parathyroid hormone (PTH 1-34), which helps increase bone density by stimulating new bone growth. It is primarily used in patients at high risk of fractures due to osteoporosis.
Uses:
-
Treatment of osteoporosis in postmenopausal women and men at high fracture risk
-
Management of osteoporosis caused by long-term corticosteroid use
-
Promotes bone formation and reduces fracture risk
Benefits:
-
Increases bone mineral density
-
Reduces risk of vertebral and non-vertebral fractures
-
Stimulates natural bone remodeling
-
Improves bone strength and quality
Composition:
-
Teriparatide (recombinant parathyroid hormone 1-34) – 100 mcg per ml
Side Effects:
-
Injection site reactions (pain, redness)
-
Dizziness or headache
-
Leg cramps
-
Hypercalcemia (high blood calcium levels)
-
Rare allergic reactions
Safety Advice:
-
Use strictly under medical supervision
-
Do not exceed prescribed dose or duration (usually max 2 years)
-
Monitor calcium levels regularly
-
Not recommended in patients with bone cancers or high risk of osteosarcoma
-
Store refrigerated between 2°C to 8°C, protect from light
